← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Allbirds' revenue contracted nearly 20% and losses and cash burn remained severe, while substantial going-concern doubt overshadows the smaller post-restructuring footprint.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 19.7%Watch
- Profitability — The net loss narrowed from $93.318M to $77.283MOK
- Cash flow — Free cash flow remained negative, with the outflow narrowing from $67.955M to $58.228MOK
- Margins — Operating margin contracted 104 bps to -52.45%Watch
- Accounting — Going-concern warning after continued contractionWatch
- Insiders — 0 purchases and 9 salesNote
Business
Allbirds designs footwear and apparel using merino wool, eucalyptus fiber, sugarcane-derived foam and other naturally derived materials.
Where the revenue comes from
Fiscal 2025, as Allbirds, Inc. reports it. History and quarterly detail are in the app.
Leadership changes
From Allbirds, Inc.'s own filings, the day they're filed.
- Ravi Thanawala · CFO · departureeff. 2026-07-14
- Joseph Zwillinger · director · departureeff. 2026-05-18
- Lily Yan Hughes · director · appointmenteff. 2025-10-31
Latest filings
- 10-Q · Quarterly report2026-08-19
- 8-K · Company announcement2026-08-19
- DEF 14A · Annual proxy (pay & governance)2026-08-11
- 8-K · Company announcement2026-08-10
- 8-K · Company announcement2026-07-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Allbirds, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.